ANNOUNCEMENT

MedCity CONVERGE gathers payers, providers, medtech, pharma, digital health, investors, policymakers and more.

Topic: Janssen

For-profit dialysis centers continued to use anemia drug after black box warning

For-profit dialysis centers continued to use anemia drug after black box warning

May 15, 2013 3:40 pm by | 0 Comments

NEW YORK (Reuters Health) - Despite a strong warning from U.S. regulators in 2007, for-profit dialysis centers still gave their kidney failure patients more of a certain anemia drug than ... Read more
Janssen R&D submits NDA for canagliflozin/metformin fixed-dose combo therapy

Janssen R&D submits NDA for canagliflozin/metformin fixed-dose combo therapy

December 12, 2012 2:05 pm by | 1 Comments

Janssen Research & Development, LLC (Janssen) today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for a fixed-dose therapy ... Read more
GSK, Janssen to start late-stage trial for rheumatoid arthritis drug sirukumab

GSK, Janssen to start late-stage trial for rheumatoid arthritis drug sirukumab

August 23, 2012 9:12 am by | 0 Comments

(Reuters) - GlaxoSmithKline Plc and Johnson & Johnson's Janssen Biologics said on Thursday they have begun late-stage trial testing of a new treatment for moderately active to severely active rheumatoid ... Read more
Pharmacyclics Triggers Significant Milestone Payment, Provides Clinical Update

Pharmacyclics Triggers Significant Milestone Payment, Provides Clinical Update

August 1, 2012 6:38 am by | 0 Comments

Pharmacyclics, Inc. (Nasdaq: PCYC) announced today that the international Phase III randomized, multicenter, open-label clinical trial, RESONATE (PCYC-1112), of ibrutinib versus ofatumumab for patients with relapsed or refractory chronic lymphocytic... ... Read more
CONVERGE product demonstration: Janssen Healthcare Innovation

CONVERGE product demonstration: Janssen Healthcare Innovation

July 11, 2012 1:20 pm by | 0 Comments

One theory behind improving patient adherence is it’s a question of memory and helping people stay better organized. For people who may be taking several medications at once, missing one ... Read more
Will Janssen’s new class of type 2 diabetes drug fare better than AZN?

Will Janssen’s new class of type 2 diabetes drug fare better than AZN?

May 31, 2012 4:00 pm by | 0 Comments

Janssen, a division of Johnson & Johnson (NYSE:JNJ) has submitted a new drug application for canagliflozin that belongs to a new class of drugs called SGLT2 inhibitors to treat type ... Read more
Cash from innovation challenges will provide pilot testing for readmission, diabetes education software

Cash from innovation challenges will provide pilot testing for readmission, diabetes education software

May 24, 2012 4:30 pm by | 1 Comments

A readmission risk assessment tool and two diabetes education programs will now be put to the ultimate reality check: patients.The winner of the Janssen Connected Care Challenge and finalists in ... Read more
Health IT tool to reduce hospital readmissions identifies vulnerable patients earlier

Health IT tool to reduce hospital readmissions identifies vulnerable patients earlier

May 14, 2012 1:49 pm by | 0 Comments

A healthcare IT program aimed at reducing hospital readmissions by more effectively coordinating vulnerable patients’ hospital discharge and follow-up care has been utilized by four hospital pilot partners.RightCare Solutions, developed ... Read more